Clinical Trial

An Ethnobridging TriaL of AGA2118 in Healthy Japanese, Chinese, and Caucasian ParticipantS (ATLAS)

Study acronym: ATLAS
Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study will evaluate the effects of a single dose of AGA2118 in Japanese, Chinese, and Caucasian participants
Protocol Amendment History 3 changes
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-07-09
notable Primary completion pushed: 2026-06 -> 2026-09 2026-07-09
minor Completion moved earlier: 2026-11 -> 2026-09 2026-07-09
Trial Details
NCT Number NCT07361354
Lead Sponsor Angitia Incorporated Limited
Conditions Healthy Participants, Pharmacokinetic Study
Enrollment 28 participants
Start Date 2026-01-05
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-07-08